|
rs1799963
|
|
A |
0.810 |
GeneticVariation |
GWASCAT |
Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.
|
26908601 |
2016 |
|
rs1799963
|
|
A |
0.810 |
SusceptibilityMutation |
CLINVAR |
Prevalence and Geographical Variation of Prothrombin G20210A Mutation in Patients with Cerebral Vein Thrombosis: A Systematic Review and Meta-Analysis.
|
27031503 |
2016 |
|
rs1799963
|
|
|
0.810 |
GeneticVariation |
BEFREE |
In multinomial multivariate adjusted analysis, rs1799963 was exclusively associated with undetermined stroke (OR: 3.67; 95% CI: 1.52-8.85; p = 0.004).
|
25897999 |
2015 |
|
rs1799963
|
|
A |
0.810 |
SusceptibilityMutation |
CLINVAR |
The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.
|
19652888 |
2009 |
|
rs1799963
|
|
A |
0.810 |
SusceptibilityMutation |
CLINVAR |
The prothrombin 3'end formation signal reveals a unique architecture that is sensitive to thrombophilic gain-of-function mutations.
|
15059842 |
2004 |
|
rs1799963
|
|
A |
0.810 |
SusceptibilityMutation |
CLINVAR |
Increased efficiency of mRNA 3' end formation: a new genetic mechanism contributing to hereditary thrombophilia.
|
11443298 |
2001 |
|
rs1188383936
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The frequently assessed hereditary thrombophilia mutations associated with stroke are methylenetetrahydrofolate reductase (MTHFR) c.677C>T, Factor V (F5) c.1691G>A (Leiden), and prothrombin (F2) c.20210G>A.
|
26522268 |
2016 |
|
rs1188383936
|
|
|
0.050 |
GeneticVariation |
BEFREE |
We tested this hypothesis by examining the influence of polymorphisms in methylenetetrahydrofolate reductase (MTHFR) (C677T) and prothrombin (F2) (G20210A) as risk factors for stroke in Morocco.
|
24132798 |
2013 |
|
rs1188383936
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The aim of this study is to determine the role of hereditary thrombophilic factors including factor V Leiden A1691G (FVL), prothrombin G20210A, and methylenetetrahydrofolate reductase (MTHFR) C677T gene mutations in patients with stroke because of cerebral infarct.
|
19263510 |
2009 |
|
rs1188383936
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The roles of ACE D polymorphism and the MTHFR C677T mutation in stroke, should also be taken into consideration in this subgroup of stroke patients.
|
10949530 |
2000 |
|
rs1188383936
|
|
|
0.050 |
GeneticVariation |
BEFREE |
The odds ratio for stroke was not significantly increased in carriers of the prothrombin mutation (OR 1.2; 95% CI 0.1-10.7), FVL (OR 2.5; 95% CI 0.5-13.5), or the C677T mutation (OR 1.7; 95% CI 0.6-4.5).
|
10365738 |
1999 |
|
rs899127658
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The frequently assessed hereditary thrombophilia mutations associated with stroke are methylenetetrahydrofolate reductase (MTHFR) c.677C>T, Factor V (F5) c.1691G>A (Leiden), and prothrombin (F2) c.20210G>A.
|
26522268 |
2016 |
|
rs899127658
|
|
|
0.030 |
GeneticVariation |
BEFREE |
The PAI-1 4G/4G genotype and the coinheritance with lipoprotein (Lp) (a) levels, the factor V (FV) G1691A mutation, the prothrombin (PT) G20210A variant, and the methylene-tetrahydrofolate reductase (MTHFR) T677T genotype were studied in 198 Caucasian children with stroke and 951 controls (same age, sex and ethnical distribution).
|
11168509 |
2001 |
|
rs899127658
|
|
|
0.030 |
GeneticVariation |
BEFREE |
One hundred forty-eight Caucasian infants and children (aged 0.5 to 16 years) with stroke and 296 age-matched controls from the same geographic areas as the patients were analyzed for increased lipoprotein (a) [Lp(a)] levels >30 mg/dL; for the presence of the factor V (FV) G1691A mutation, the prothrombin (PT) G20210A variant, and the TT677 genotype of methylenetetrahydrofolate reductase (MTHFR); and deficiencies of protein C, protein S, and antithrombin.
|
10572079 |
1999 |
|
rs1183194405
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The factor V Leiden mutation was over-represented in patients with cardioembolic stroke for trend, whereas the prothrombin 20210G-->A variant and the factor XIII polymorphism Val34Leu were not associated with stroke of any subtype.
|
19660184 |
2010 |